| Application of Noscapine in the treatment of stroke | The effect of Noscapine on first month mortality rate of massive ischemic strokes | IRCT138809282886N1 |
| The effect of Noscapine on clinical and pulmonary manifestations of COVID-19 patients | The effect of NOSCOVID on pulmonary & other clinical manifestations of COVID-19 patients | IRCT20160625028622N1 |
| Study to compare two different oral preparations of noscapine in order to proof equality of both drugs | A randomised, two-period two-stage cross-over study on the relative bioavailability of two different liquid formulations of single noscapine doses (phase I/IV, open-label) in healthy volunteers (fasted state) | EUCTR2019-002012-12-DE |
| Study to compare two different oral preparations of noscapine in order to proof equality of both drugs | A randomised, two-period two-stage cross-over study on the relative bioavailability of two different formulations of single doses of noscapine (phase I/IV, open-label) in healthy volunteers (fasted state) | EUCTR2014-003151-62-DE |
| Evaluation of the combined effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19 | effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19 | IRCT20181030041504N1 |
| Study of noscapine in Buerger's disease | Evaluation of the effectiveness of noscapine capsules in patients with Buerger's disease | IRCT20180103038199N5 |
| effects of three products containing Noscapine on COVID-19 | Evaluation and comparison of the effectiveness of three herbal products containing Noscapine (Opiucough, Noscough and Noscatem) on clinical symptoms and para-clinical parameters in adults hospitalized with severe COVID-19 | IRCT20180103038199N3 |
| Evaluation of the Effects of Noscapine on the Treatment of Patients with COVID-19 | Evaluation of the Effects of Noscapine on the Treatment of Cough in COVID-19 Outpatients | IRCT20151227025726N31 |
| Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy | Phase I/II Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy | NCT00183950 |
| A clinical study to assess the efficacy and safety of combination of Noscapine plus Chlorpheniramine Syrup in patients for the treatment of cough with running nose. | ââ?¬Å?A Phase III, Prospective, Randomized, Double Blind, Active-Controlled, Comparative, Parallel Group, Multicentric Clinical Study to Evaluate the Efficacy, Safety and Tolerability of FDC of Noscapine and Chlorpheniramine Maleate Oral Syrup in Patients for the Treatment of Dry, Irritating Cough Associated with Running Nose.ââ?¬? | CTRI/2022/03/041394 |
| A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma | A Phase I Open Label Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma | NCT00912899 |
